You are here

SARC018_SPORE02

Active
A Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse Following Prior Treatment with Gemcitabine-Containing Therapy
Type of Sarcoma: 
Metastatic Leiomyosarcoma
Drug: 
Mocetinostat & Gemcitabine
Accrual Status: 
Open, Not Accruing
Overall Study Principal Investigator: 
Shreyas Patel, MD
Co-Principal Investigator
MD Anderson Cancer Center

Edwin Choy, MD, PhD
Co-Principal Investigator
MGH, Dana Farber/Harvard Cancer Center
Division of Hematology Oncology
 

For more information about this trial and open sites: